Nucleus® Implant reliability

With a cochlear Implant, it is essential to choose the best hearing solution for today and for the future. That's why reliability is so important.

Grandson whispers to grandpa

What you'll find on this page

  • Learn why implant reliability is important.
  • Discover why Cochlear™ Nucleus® Implants are the most reliable today for both adults and children.
  • Hear from Cochlear's first ever child recipient - 30 years after she received her implant.

Reliability you can count on

Choosing a cochlear implant is an important decision. Be it for themself or a loved one, patients want to trust that they are choosing the right hearing solution for today and for the future.

Along with hearing performance, the reliability of the implant is a measure of quality and can provide peace of mind for the years to come. That's why it matters that Cochlear Nucleus Implants are the most reliable in the industry.1-3

The latest Cochlear Nucleus ProfileTM Plus Series continues its position of leading reliability within Cochlear's implant portfolio. The Profile Plus Series Implant features a cumulative survival percentage (CSP) of 99.91% within 3 years from over 45,000 registered devices.1

The Cochlear Nucleus Profile Series Implant has shown reliability at 99.72% CSP within 8 years from over 100,000 registered devices.1

The Cochlear Nucleus CI24RE Series Implant has a long term reliability of 98.99% CSP within 17 years with more than 208,000 registered devices.1

Transparency is important to us, so we meet and report against independent global standards for implant reliability, publishing data of every implant generation, past and present.4-8

Stat-ProfilePlus2022.png 

Most reliable for children1,3

When choosing a hearing implant for a child, we understand that parents will want the very best. Cochlear has market-leading implant reliability rates for children, with 99.66% CSP* within eight years for our Nucleus Profile Series Implant and 99.87% CSP within three years for our Nucleus Profile Plus Series Implant.

Most chosen**

With more than 475,000 registered Cochlear Nucleus Implants worldwide,1 Cochlear leads the way as the most chosen provider of implantable hearing solutions.

 

Cochlear Nucleus System Reliability Report

Volume 20 - December 2021 | PDF

1.9 MB | PDF

Download now

Why cochlear implant reliability matters

Cochlear's first commercial child recipient, Holly Taylor, has relied on her Cochlear Implant for more than 30 years. Discover why Holly says, "I choose quality. I choose Cochlear."

Holly is an immediate family member of a former employee of Cochlear Limited.

Disclaimer

Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.

For a full list of Cochlear’s trademarks, please visit our Terms of Use page.

Views expressed are those of the individual. Consult your health professional to determine if you are a candidate for Cochlear technology.

Any testimonial featured is not intended for a New Zealand audience.

In Australia, Cochlear™ Nucleus® Implant systems are intended for the treatment of moderately severe to profound hearing loss.

For Cochlear™ Nucleus® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your healthcare professional.

* CSP = Cumulative Survival Percentage. CSP includes both device and accident related issues.

** Based on the manufacturers that do report compliantly with the European Consensus Statement as the requirements ask for sample population as well as data to be split into adults versus children.

References
  1. D1932780 Cochlear Nucleus Reliability Report Volume 20 December 2021, March 2022
  2. Cochlear Implant Reliability | MED-EL [Internet]. Medel.com. 2022 [cited 1 March 2022]. Available from: http://www.medel.com/hearing-solutions/cochlear-implants/reliability.
  3. Advanced Bionics Reliability Report Autumn 2021. 027-N258-02 Rev D. Advanced Bionics AG and affiliates.; 2021.
  4. International Standard ISO 5841-2. Implants for Surgery — Cardiac Pacemakers — Part 2: Reporting of Clinical Performance of Populations of Pulse Generators or Leads. Geneva (Switzerland): International Organization for Standardization. 2000.
  5. International Standard ISO 5841-2. Implants for Surgery — Cardiac Pacemakers — Part 2: Reporting of Clinical Performance of Populations of Pulse Generators or Leads. Geneva (Switzerland): International Organization for Standardization. 2014.
  6. European Consensus Statement on Cochlear Implant Failures and Explantations. Otol Neurotol. 2005 Nov;26(6):1097-9.
  7. Battmer RD, Backous DD, Balkany TJ, Briggs RJ, Gantz BJ, van Hasselt A, et al. International Classification of Reliability for Implanted Cochlear Implant Receiver Stimulators. Otol Neurotol. 2010 Oct;31(8):1190-3.
  8. ANSI/AAMI CI86. Cochlear implant systems: Requirements for safety, functional verification,. (2017). Arlington, VA: American National Standards Institute.